Skip to content

An open controlled study of testicular local injection of autologous platelet rich plasma in the treatment of non obstructive azoospermia

An open controlled study of testicular local injection of autologous platelet rich plasma in the treatment of non obstructive azoospermia - An open controlled study of testicular local injection of autologous PRP in the treatment of NOA

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500100258
Enrollment
Unknown
Registered
2025-04-07
Start date
2025-04-07
Completion date
Unknown
Last updated
2025-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-obstructive azoospermia

Interventions

Treatment group:Autologous PRP testicular local multipoint injection

Sponsors

Xiangtan Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: (1) Age 18 to 50 years; (2) Patients diagnosed with non-obstructive azoospermia; (3) The patient requests microscopic sperm retrieval; (4) Willing to have children and accept further treatment; (5) Able to understand and sign informed consent.

Exclusion criteria

Exclusion criteria: (1) Acute inflammation of the reproductive system; (2) Thrombocytopenia or use of anticoagulant medications; (3) Abnormal nodules or masses in the testes; (4) Malignant tumors; (5) Other infectious diseases; (6) Severe liver, kidney, cardiovascular, cerebrovascular, and hematological diseases.

Design outcomes

Primary

MeasureTime frame
Whether spermatozoa is obtained by microscopic sperm retrieval;

Secondary

MeasureTime frame
Follicle-stimulating hormone;Luteinizing hormone;Testosterone;The presence or absence of sperm in the semen;

Countries

China

Contacts

Public ContactJiang yunshan

Xiangtan Central Hospital

jiangys0910@163.com+86 186 7022 1488

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026